|
Name |
Diepoxin gamma
|
Molecular Formula | C20H16O8 | |
IUPAC Name* |
(1'S,2'S,3'R,5'R,7'R,10'S,11'S)-2',10',11'-trihydroxyspiro[2,4-dioxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaene-3,6'-4,12-dioxatetracyclo[5.4.1.01,7.03,5]dodecane]-8'-one
|
|
SMILES |
C1[C@@H]([C@@H]([C@]23[C@H]([C@@H]4[C@@H](O4)C5([C@@]2(C1=O)O3)OC6=CC=CC7=C6C(=CC=C7)O5)O)O)O
|
|
InChI |
InChI=1S/C20H16O8/c21-9-7-12(22)19-18(28-19,15(9)23)16(24)14-17(25-14)20(19)26-10-5-1-3-8-4-2-6-11(27-20)13(8)10/h1-6,9,14-17,21,23-24H,7H2/t9-,14+,15-,16-,17+,18-,19-/m0/s1
|
|
InChIKey |
AEHDWPXNIOFWQB-RSLGSOOPSA-N
|
|
Synonyms |
Diepoxin gamma; Diepoxin G; CHEMBL3342641
|
|
CAS | NA | |
PubChem CID | 15283755 | |
ChEMBL ID | CHEMBL3342641 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.3 | ALogp: | -0.5 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 121.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 28 | QED Weighted: | 0.546 |
Caco-2 Permeability: | -5.774 | MDCK Permeability: | 0.00003760 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.991 |
Human Intestinal Absorption (HIA): | 0.15 | 20% Bioavailability (F20%): | 0.083 |
30% Bioavailability (F30%): | 0.945 |
Blood-Brain-Barrier Penetration (BBB): | 0.711 | Plasma Protein Binding (PPB): | 88.63% |
Volume Distribution (VD): | 0.454 | Fu: | 3.69% |
CYP1A2-inhibitor: | 0.077 | CYP1A2-substrate: | 0.719 |
CYP2C19-inhibitor: | 0.035 | CYP2C19-substrate: | 0.597 |
CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.041 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.193 |
CYP3A4-inhibitor: | 0.027 | CYP3A4-substrate: | 0.422 |
Clearance (CL): | 11.361 | Half-life (T1/2): | 0.65 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.993 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.932 |
Rat Oral Acute Toxicity: | 0.7 | Maximum Recommended Daily Dose: | 0.043 |
Skin Sensitization: | 0.86 | Carcinogencity: | 0.881 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.023 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003239 | 1.000 | D0Q3VE | 0.242 | ||||
ENC003238 | 0.831 | D08CCE | 0.228 | ||||
ENC001999 | 0.717 | D06ALD | 0.217 | ||||
ENC001988 | 0.681 | D06TJJ | 0.216 | ||||
ENC002185 | 0.663 | D01TNW | 0.215 | ||||
ENC003195 | 0.656 | D00JRA | 0.211 | ||||
ENC003194 | 0.606 | D06BQU | 0.205 | ||||
ENC003198 | 0.580 | D0AZ8C | 0.203 | ||||
ENC003197 | 0.559 | D08DFX | 0.201 | ||||
ENC003196 | 0.544 | D05MQK | 0.197 |